Carsten Brink

Professor, medical physics Radiofysisk laboratorium, Odense University Hospital carsten.brink@rsyd.dk
Research interests

DK: Forskningsområder dækker blandt andet Radiomics (udtræk af biologisk information fra medicinske billeder) samt statistisk modellering af tumor kontrol og normalvævs skade.

UK: Research areas cover Radiomics (extract of biological information from medical images) and statistical modelling of tumour control and normal tissue damage. 

Workgroups Publications
  • Kaae JK, Stenfeldt L, Hyrup B, Brink C, Eriksen JG A randomized phase III trial for alleviating radiation-induced xerostomia with chewing gum. Radiother Oncol. 2019 Oct 9. 2019
  • Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019 Oct;58(10):1373-1377. 2019
  • Kaae JK, Johnsen L, Hansen CR, Kristensen MH, Brink C, Eriksen JG Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy. Acta Oncol. 2019 Oct;58(10):1366-1372. 2019
  • Zukauskaite R, Hansen CR, Grau C, Samsøe E, Johansen J, Petersen JBB, Andersen E, Brink C, Overgaard J, Eriksen JG Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins. Radiother Oncol. 2018 Jan;126(1):48-55. 2018
  • Bertelsen AS, Schytte T, Møller PK, Mahmood F, Riis HL, Gottlieb KL, Agergaard SN, Dysager L, Hansen O, Gornitzka J, Veldhuizen E, ODwyer DB, Christiansen RL, Nielsen M, Jensen HR, Brink C, Bernchou U First clinical experiences with a high field 1.5 T MR linac. Acta Oncol. 2019 Oct;58(10):1352-1357. 2019
  • Brink C, Lorenzen EL, Krogh SL, Westberg J, Berg M, Jensen I, Thomsen MS, Yates ES, Offersen BV DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting. Acta Oncol. 2018 Jan;57(1):107-112. 2018
  • Christiansen RL, Hansen CR, Dahlrot RH, Bertelsen A, Hansen O, Brink C, Bernchou U. Plan quality for high-risk prostate cancer treated with high field magnetic resonance imaging guided radiotherapy. Physics and Imaging in Radiation Oncology, 7, 1-8. 2018
  • van Timmeren JE, van Elmpt W, de Ruysscher D, Reymen B, Hansen O, Brink C. Tumor regression during radiotherapy for non-small cell lung cancer patients using cone-beam computed tomography images. Strahlenther Onkol. 2020 Feb;196(2):159-171. 2019
  • Hansen CR, Bertelsen A, Zukauskaite R, Johnsen L, Bernchou U, Thwaites DI, Eriksen JG, Johansen J, Brink C Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort Radiother Oncol. 2020 Jun;147:15-21. 2020
  • Laugaard Lorenzen E, Christian Rehammar J, Jensen MB, Ewertz M, Brink C Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977-2005. Radiother Oncol. 2020 Aug 25:S0167-8140(20)30725-8. 2020